from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit: us-gaap: shares
Description: Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary: ACCENDRA HEALTH INC/VA/ quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2010 to 31 Dec 2025.
ACCENDRA HEALTH INC/VA/ Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 76,897,000, a 0.2% increase year-over-year.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 76,897,000, a 0.2% increase from 2024.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 76,741,000, a 1.3% increase from 2023.
ACCENDRA HEALTH INC/VA/ annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 75,785,000, a 1.7% increase from 2022.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Basic, Annual (shares)

Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	76,897,000	+156,000	+0.2%	01 Oct 2025	31 Dec 2025	10-K	20 Feb 2026	2025	FY
Q3 2025	77,288,000	+198,000	+0.26%	01 Jul 2025	30 Sep 2025	10-Q	31 Oct 2025	2025	Q3
Q2 2025	76,935,000	+208,000	+0.27%	01 Apr 2025	30 Jun 2025	10-Q	11 Aug 2025	2025	Q2
Q1 2025	77,272,000	+953,000	+1.2%	01 Jan 2025	31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	76,741,000	+956,000	+1.3%	01 Oct 2024	31 Dec 2024	10-K	20 Feb 2026	2025	FY
Q3 2024	77,090,000	+887,000	+1.2%	01 Jul 2024	30 Sep 2024	10-Q	31 Oct 2025	2025	Q3
Q2 2024	76,727,000	+926,000	+1.2%	01 Apr 2024	30 Jun 2024	10-Q	11 Aug 2025	2025	Q2
Q1 2024	76,319,000	+1,142,000	+1.5%	01 Jan 2024	31 Mar 2024	10-Q	08 May 2025	2025	Q1
Q4 2023	75,785,000	+1,289,000	+1.7%	01 Oct 2023	31 Dec 2023	10-K	20 Feb 2026	2025	FY
Q3 2023	76,203,000	+1,298,000	+1.7%	01 Jul 2023	30 Sep 2023	10-Q	04 Nov 2024	2024	Q3
Q2 2023	75,801,000	+1,091,000	+1.5%	01 Apr 2023	30 Jun 2023	10-Q	02 Aug 2024	2024	Q2
Q1 2023	75,177,000	+1,534,000	+2.1%	01 Jan 2023	31 Mar 2023	10-Q	03 May 2024	2024	Q1
Q4 2022	74,496,000	+1,752,000	+2.4%	01 Oct 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
Q3 2022	74,905,000	+1,690,000	+2.3%	01 Jul 2022	30 Sep 2022	10-Q	03 Nov 2023	2023	Q3
Q2 2022	74,710,000	+1,892,000	+2.6%	01 Apr 2022	30 Jun 2022	10-Q	04 Aug 2023	2023	Q2
Q1 2022	73,643,000	+2,809,000	+4%	01 Jan 2022	31 Mar 2022	10-Q	05 May 2023	2023	Q1
Q4 2021	72,744,000	+9,376,000	+15%	01 Oct 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
Q3 2021	73,215,000	+12,429,000	+20%	01 Jul 2021	30 Sep 2021	10-Q	02 Nov 2022	2022	Q3
Q2 2021	72,818,000	+11,690,000	+19%	01 Apr 2021	30 Jun 2021	10-Q	03 Aug 2022	2022	Q2
Q1 2021	70,834,000	+10,263,000	+17%	01 Jan 2021	31 Mar 2021	10-Q	04 May 2022	2022	Q1
Q4 2020	63,368,000			01 Oct 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
Q3 2020	60,786,000	+756,000	+1.3%	01 Jul 2020	30 Sep 2020	10-Q	03 Nov 2021	2021	Q3
Q2 2020	61,128,000			01 Apr 2020	30 Jun 2020	10-Q	03 Aug 2021	2021	Q2
Q1 2020	60,571,000			01 Jan 2020	31 Mar 2020	10-Q	05 May 2021	2021	Q1
Q3 2019	60,030,000			01 Jul 2019	30 Sep 2019	10-Q	03 Nov 2020	2020	Q3
Q4 2016	61,093,000	-1,023,000	-1.6%	01 Oct 2016	31 Dec 2016	10-K	23 Feb 2018	2017	FY
Q3 2016	61,015,000	-983,000	-1.6%	01 Jul 2016	30 Sep 2016	10-Q	02 Nov 2016	2016	Q3
Q2 2016	61,502,000	-724,000	-1.2%	01 Apr 2016	30 Jun 2016	10-Q	03 Aug 2016	2016	Q2
Q1 2016	61,696,000	-568,000	-0.91%	01 Jan 2016	31 Mar 2016	10-Q	04 May 2016	2016	Q1
Q4 2015	62,116,000	-104,000	-0.17%	01 Oct 2015	31 Dec 2015	10-K	23 Feb 2018	2017	FY
Q3 2015	61,998,000	-177,000	-0.28%	01 Jul 2015	30 Sep 2015	10-Q	02 Nov 2016	2016	Q3
Q2 2015	62,226,000	-85,000	-0.14%	01 Apr 2015	30 Jun 2015	10-Q	03 Aug 2016	2016	Q2
Q1 2015	62,264,000	-40,000	-0.06%	01 Jan 2015	31 Mar 2015	10-Q	04 May 2016	2016	Q1
Q4 2014	62,220,000	-405,000	-0.65%	01 Oct 2014	31 Dec 2014	10-K	17 Feb 2017	2016	FY
Q3 2014	62,175,000	-430,000	-0.69%	01 Jul 2014	30 Sep 2014	10-Q	28 Oct 2015	2015	Q3
Q2 2014	62,311,000	-396,000	-0.63%	01 Apr 2014	30 Jun 2014	10-Q	28 Jul 2015	2015	Q2
Q1 2014	62,304,000	-383,000	-0.61%	01 Jan 2014	31 Mar 2014	10-Q	28 Apr 2015	2015	Q1
Q4 2013	62,625,000	-140,000	-0.22%	01 Oct 2013	31 Dec 2013	10-K	25 Feb 2016	2015	FY
Q3 2013	62,605,000	-158,000	-0.25%	01 Jul 2013	30 Sep 2013	10-Q	29 Oct 2014	2014	Q3
Q2 2013	62,707,000	-108,000	-0.17%	01 Apr 2013	30 Jun 2013	10-Q	30 Jul 2014	2014	Q2
Q1 2013	62,687,000	-115,000	-0.18%	01 Jan 2013	31 Mar 2013	10-Q	01 May 2014	2014	Q1
Q4 2012	62,765,000	+9,000	+0.01%	01 Oct 2012	31 Dec 2012	10-K	23 Feb 2015	2014	FY
Q3 2012	62,763,000	-39,000	-0.06%	01 Jul 2012	30 Sep 2012	10-Q	07 Nov 2013	2013	Q3
Q2 2012	62,815,000	-192,000	-0.3%	01 Apr 2012	30 Jun 2012	10-Q	02 Aug 2013	2013	Q2
Q1 2012	62,802,000	+161,000	+0.26%	01 Jan 2012	31 Mar 2012	10-Q	03 May 2013	2013	Q1
Q4 2011	62,756,000			01 Oct 2011	31 Dec 2011	10-K	25 Feb 2014	2013	FY
Q3 2011	62,802,000	+407,000	+0.65%	01 Jul 2011	30 Sep 2011	10-Q	02 Nov 2012	2012	Q3
Q2 2011	63,007,000	+673,000	+1.1%	01 Apr 2011	30 Jun 2011	10-Q	27 Jul 2012	2012	Q2
Q1 2011	62,641,000			01 Jan 2011	31 Mar 2011	10-Q	27 Apr 2012	2012	Q1
Q3 2010	62,395,000			01 Jul 2010	30 Sep 2010	10-Q	28 Oct 2011	2011	Q3
Q2 2010	62,334,000			01 Apr 2010	30 Jun 2010	10-Q	29 Jul 2011	2011	Q2

ACCENDRA HEALTH INC/VA/ Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2025	76,897,000	+156,000	+0.2%	01 Jan 2025	31 Dec 2025	10-K	20 Feb 2026	2025	FY
2024	76,741,000	+956,000	+1.3%	01 Jan 2024	31 Dec 2024	10-K	20 Feb 2026	2025	FY
2023	75,785,000	+1,289,000	+1.7%	01 Jan 2023	31 Dec 2023	10-K	20 Feb 2026	2025	FY
2022	74,496,000	+1,752,000	+2.4%	01 Jan 2022	31 Dec 2022	10-K	28 Feb 2025	2024	FY
2021	72,744,000	+9,376,000	+15%	01 Jan 2021	31 Dec 2021	10-K	20 Feb 2024	2023	FY
2020	63,368,000	+2,794,000	+4.6%	01 Jan 2020	31 Dec 2020	10-K	28 Feb 2023	2022	FY
2019	60,574,000			01 Jan 2019	31 Dec 2019	10-K	23 Feb 2022	2021	FY
2017	60,001,000	-1,092,000	-1.8%	01 Jan 2017	31 Dec 2017	10-K	23 Feb 2018	2017	FY
2016	61,093,000	-1,023,000	-1.6%	01 Jan 2016	31 Dec 2016	10-K	23 Feb 2018	2017	FY
2015	62,116,000	-104,000	-0.17%	01 Jan 2015	31 Dec 2015	10-K	23 Feb 2018	2017	FY
2014	62,220,000	-405,000	-0.65%	01 Jan 2014	31 Dec 2014	10-K	17 Feb 2017	2016	FY
2013	62,625,000	-140,000	-0.22%	01 Jan 2013	31 Dec 2013	10-K	25 Feb 2016	2015	FY
2012	62,765,000	+9,000	+0.01%	01 Jan 2012	31 Dec 2012	10-K	23 Feb 2015	2014	FY
2011	62,756,000	+441,000	+0.71%	01 Jan 2011	31 Dec 2011	10-K	25 Feb 2014	2013	FY
2010	62,315,000			01 Jan 2010	31 Dec 2010	10-K	22 Feb 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.